In breast cancer cells, the accumulation of misfolding-prone proteins in the mitochondrial intermembrane space (IMS) interferes with ETC homeostasis, leading to an increase in the level of ROS in the IMS and subsequently triggering the activation of estrogen receptor α (ERα or ESR1) (Fig. 2). This evidence concerns the gene ESR1 and breast carcinoma.